US-CHINA BIOMEDICAL TECHNOLOGY, INC.

Inactive Instrument

Insiders US-China Biomedical Technology, Inc.

Equities

UCBB

US91734Q1040

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

US-China Biomedical Technology, Inc. Receives Resignation of Wentie Sun as a Member of the Board	12/06/19	CI
Safa Movassaghi Resigns as Vice President and Joins as Member of the Board of US-China Biomedical Technology, Inc	22/03/19	CI
US-China Biomedical Technology, Inc. Announces Resignation of Rand Scott as Member of the Board	07/01/19	CI
US-China Biomedical Technology, Inc. Appoints Safa Movassaghi as Vice President	07/11/18	CI
US-China Biomedical Technology, Inc. Appoints Wentie Robert Sun as a Member of Board	04/09/18	CI
US-China Biomedical Technology, Inc. Appoints H. Rand Scott as a Member of the Board	18/07/18	CI
Cloud Security Corporation will Change its Name to US-China Biomedical Technology, Inc	30/01/18	CI
Cloud Security Corporation Announces Resignation of Amanda Huang as Senior Vice President	11/01/18	CI
Cloud Security Corporation Announces Management Changes	01/12/17	CI
Cloud Security Corporation Announces Executive Changes	01/08/17	CI
Cloud Security Corporation Announces Management Changes	23/06/17	CI
Cloud Security Corporation Announces Management Changes	13/01/17	CI
Cloud Security Corporation Appoints Sam Liu as Secretary of the Corporation	17/09/15	CI
Cloud Security Corporation Announces Resignation of Zhen Mu as Member of the Board and Secretary	21/08/15	CI
Cloud Security Corporation Announces Executive Changes	13/02/15	CI
Cloud Security Corporation Announces Resignation of Walter Grieves as Member of the Board of Directors	07/11/14	CI
Cloud Star Corporation has Changed its Name to Cloud Security Corporation	28/05/13	CI
Cloud Star Corporation Hires Wee Kai Ng as Chief Technology Advisor	02/04/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer